Genetic association study of age-related macular degeneration in the Spanish population

Acta Ophthalmologica

Volumn 89, Issue 1, 2011, Pages

  Briõn, María ^a   Sanchez Salorio, Manuel ^c   Cortõn, Marta ^b   De La Fuente, Maria ^c   Pazos, Belen ^c   Othman, Mohammad ^d   Swaroop, Anand ^d   Abecasis, Goncalo ^d   Sobrino, Beatriz ^b   Carracedo, Angel ^b,e  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c Fundación Instituto Gallego de Oftalmología   (Spain)

^d UNIVERSITY OF MICHIGAN   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

Author keywords

ABCA4; age related macular degeneration; ARMS2; case control study; CFH; FGF2; genetic association

Indexed keywords

3' UNTRANSLATED REGION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTEINS; QUESTIONNAIRES; RISK FACTORS; SPAIN;

EID: 79551560263     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02040.x     Document Type: Article

References (73)

1. Abecasis GR, Yashar BM, Zhao Y, et al. (2004): Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 74: 482-494.
2. Age-Related Eye Disease Study Research Group (2000): Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-Related Eye Disease Study Report Number 3. Ophthalmology 107: 2224-2232.
3. Allikmets R, Shroyer NF, Singh N, et al. (1997): Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277: 1805-1807.
4. Baguma-Nibasheka M, Li AW, &, Murphy PR, (2007): The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol Cell Endocrinol 267: 127-136.
5. Baird PN, Chu D, Guida E, Vu HT, &, Guymer R, (2004): Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 138: 665-666.
6. Barral S, Francis PJ, Schultz DW, et al. (2006): Expanded genome scan in extended families with age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 5453-9.
7. Barrett JC, Fry B, Maller J, &, Daly MJ, (2005): Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
8. Bojanowski CM, Tuo J, Chew EY, Csaky KG, &, Chan CC, (2005): Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration. Trans Am Ophthalmol Soc 103: 37-44. discussion 44-45.
9. Browning AC, Dua HS, &, Amoaku WM, (2008): The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells. Br J Ophthalmol 92: 1003-1008.
10. Cameron DJ, Yang Z, Gibbs D, et al. (2007): HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6: 1122-1125. (Pubitemid 46708586)
11. Deangelis MM, Ji F, Adams S, et al. (2008): Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 115: 1209-1215.
12. Despriet DD, Bergen AA, Merriam JE, et al. (2008): Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 364-371.
13. Dewan A, Liu M, Hartman S, et al. (2006): HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314: 989-992.
14. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, &, Farrer LA, (2005): Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
15. Edwards AO, Chen D, Fridley BL, et al. (2008): Toll-like receptor polymorphisms and age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 1652-1659.
16. Esfandiary H, Chakravarthy U, Patterson C, Young I, &, Hughes AE, (2005): Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 89: 470-474. (Pubitemid 40469968)
17. Fisher SA, Abecasis GR, Yashar BM, et al. (2005): Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14: 2257-2264.
18. Fisher SA, Rivera A, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Rudolph G, &, Weber BH, (2007): Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD). Hum Mutat 28: 406-413.
19. Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, &, Klein ML, (2007): Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS ONE 2: e1197.
20. Frank RN, (1997): Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 29: 341-353.
21. Friedman DS, O'Colmain BJ, Munoz B, et al. (2004): Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572.
22. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN, &, Weber BH, (2008): Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40: 892-896.
23. de la Fuente M, Blanco MJ, Pazos B, et al. (2007): Complement factor H. Ophthalmology 114: 193.e1-193.e2.
24. Fuse N, Miyazawa A, Mengkegale M, Yoshida M, Wakusawa R, Abe T, &, Tamai M, (2006): Polymorphisms in Complement Factor H and Hemicentin-1 genes in a Japanese population with dry-type age-related macular degeneration. Am J Ophthalmol 142: 1074-1076.
25. Gabriel SB, Schaffner SF, Nguyen H, et al. (2002): The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
26. Gold B, Merriam JE, Zernant J, et al. (2006): Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
27. Guymer RH, Heon E, Lotery AJ, et al. (2001): Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 119: 745-751.
28. Hageman GS, Anderson DH, Johnson LV, et al. (2005): A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102: 7227-7232.
29. Hageman GS, Hancox LS, Taiber AJ, et al. (2006): Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38: 592-604.
30. Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, &, Dunaief JL, (2004): Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 101: 13850-13855.
31. HapMap CI, (2003): The International HapMap Project. Nature 426: 789-796.
32. Hayashi M, Merriam JE, Klaver CC, et al. (2004): Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 25: 111-119.
33. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, &, Chakravarthy U, (2006): A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38: 1173-1177.
34. Jager RD, Mieler WF, &, Miller JW, (2008): Age-related macular degeneration. N Engl J Med 358: 2606-2617.
35. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, &, Gorin MB, (2005): Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77: 389-407.
36. Jun G, Klein BE, Klein R, et al. (2005): Genome-wide analyses demonstrate novel loci that predispose to drusen formation. Invest Ophthalmol Vis Sci 46: 3081-3088.
37. Kanda A, Chen W, Othman M, et al. (2007): A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 104: 16227-16232.
38. Kang HJ, Choi KO, Kim BD, Kim S, &, Kim YJ, (2005): FESD: a Functional Element SNPs Database in human. Nucleic Acids Res 33: D518-D522.
39. Kaur I, Hussain A, Hussain N, et al. (2006): Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 3729-3735.
40. Klein RJ, Zeiss C, Chew EY, et al. (2005): Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
41. Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, &, Mooy CM, (2003): Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 44: 2192-2198.
42. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, &, de Jong PT, (2003): The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121: 519-526.
43. Li M, Atmaca-Sonmez P, &, Othman M, (2006): CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38: 1049-1054.
44. Majewski J, Schultz DW, Weleber RG, et al. (2003): Age-related macular degeneration-a genome scan in extended families. Am J Hum Genet 73: 540-550.
45. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, &, Seddon JM, (2007): Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39: 1200-1201.
46. Martin G, Schlunck G, Hansen LL, &, Agostini HT, (2004): Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 242: 321-326.
47. Morcillo-Suarez C, Alegre J, Sangros R, et al. (2008): SNP analysis to results (SNPator): a web-based environment oriented to statistical genomics analyses upon SNP data. Bioinformatics 24: 1643-1644.
48. Mullins RF, Russell SR, Anderson DH, &, Hageman GS, (2000): Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14: 835-846.
49. Ogata N, Matsushima M, Takada Y, et al. (1996): Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res 15: 1008-1018. (Pubitemid 26360037)
50. Ormsby RJ, Ranganathan S, Tong JC, et al. (2008): Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 1763-1770.
51. Rakic JM, Lambert V, Munaut C, et al. (2003): Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 1732-1739.
52. Recalde S, Fernandez-Robredo P, Altarriba M, Salinas-Alaman A, &, Garcia-Layana A, (2008): Age-related macular degeneration genetics. Ophthalmology 115: 916-916.
53. Richardson AJ, Islam FM, Guymer RH, Cain M, &, Baird PN, (2007): A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 13: 2148-2152.
54. Rivera A, White K, Stohr H, et al. (2000): A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 67: 800-813.
55. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, &, Weber BH, (2005): Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14: 3227-3236.
56. Schmidt S, Postel EA, Agarwal A, et al. (2003): Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci 44: 2868-2875.
57. Schmidt S, Haines JL, Postel EA, Agarwal A, Kwan SY, Gilbert JR, Pericak-Vance MA, &, Scott WK, (2005): Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 11: 941-949.
58. Schmidt S, Hauser MA, Scott WK, et al. (2006): Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78: 852-864.
59. Schultz DW, Klein ML, Humpert A, Majewski J, Schain M, Weleber RG, Ott J, &, Acott TS, (2003): Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 121: 679-683.
60. Seddon JM, Ajani UA, &, Mitchell BD, (1997): Familial aggregation of age-related maculopathy. Am J Ophthalmol 123: 199-206.
61. Seitsonen S, Lemmela S, Holopainen J, et al. (2006): Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol Vis 12: 796-801.
62. Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, &, Lupski JR, (2001): Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 10: 2671-2678.
63. Skerka C, Lauer N, Weinberger AA, et al. (2007): Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol 44: 3398-3406.
64. Souied EH, Ducroq D, Rozet JM, et al. (2000): ABCR gene analysis in familial exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 41: 244-247. (Pubitemid 30036573)
65. Swaroop A, Chew EY, Rickman CB, &, Abecasis GR, (2009): Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 10: 19-43.
66. Tanimoto S, Tamura H, Ue T, Yamane K, Maruyama H, Kawakami H, &, Kiuchi Y, (2007): A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population. Neurosci Lett 414: 71-74.
67. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, &, Kelly SP, (2005): Smoking and age-related macular degeneration: a review of association. Eye 19: 935-944.
68. Tobler AR, Short S, Andersen MR, et al. (2005): The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 16: 398-406.
69. Utheim OA, Ritland JS, Utheim TP, Espeseth T, Lydersen S, Rootwelt H, Semb SO, &, Elsas T, (2008): Apolipoprotein E genotype and risk for development of cataract and age-related macular degeneration. Acta Ophthalmol 86: 401-403.
70. Weeks DE, Conley YP, Tsai HJ, et al. (2004): Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75: 174-189.
71. Weger M, Renner W, Steinbrugger I, et al. (2007): Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis 13: 1274-1279. (Pubitemid 47128954)
72. Yates JR, Sepp T, Matharu BK, et al. (2007): Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
73. Yu J, Wiita P, Kawaguchi R, Honda J, Jorgensen A, Zhang K, Fischetti VA, &, Sun H, (2007): Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry 46: 8451-8461.